Michael W. Dunne - 01 Jul 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Director
Signature: /s/ Michael W. Dunne
Issuer symbol: ITRM
Transactions as of: 01 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Jul 2023, 08:00:07 UTC
Previous filing: 15 Jun 2023
Next filing: 02 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise		+1,779	+3.3%		55,267	01 Jul 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Restricted Share Units	Options Exercise	$0	-1,779	-100%	$0.000000^*	0	01 Jul 2023	Ordinary Shares	1,779		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2	On September 25, 2022, the reporting person was granted an award of 1,799 RSUs, which vested in full on July 1, 2023.